Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2015 Financial and Operating Results on March 29, 2016
March 15 2016 - 8:00AM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the
“Company”) will announce its fourth quarter and full-year 2015
financial and operating results after market close on Tuesday,
March 29, 2016. The Company will host a conference call and webcast
to discuss these results on Wednesday, March 30, 2016 at 8:00 a.m.
Eastern Time.
Participants may access the live webcast via the Company's
website at www.aezsinc.com, or by telephone using the following
number: 201-689-8029, Confirmation #13632538. A replay of the
webcast will also be available on the Company’s website for a
period of 30 days.
For reference, the Management’s Discussion and Analysis of
Financial Condition and Results of Operations for the fourth
quarter and full-year 2015, as well as the Company’s audited
consolidated financial statements as at December 31, 2015, 2014 and
2013, can be found at www.aezsinc.com in the “Investors/Regulatory
Filings” section.
About Aeterna Zentaris
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel treatments in
oncology, endocrinology and women’s health. We are engaged in drug
development activities and in the promotion of products for others.
We are now conducting Phase 3 studies of two internally developed
compounds. The focus of our business development efforts is the
acquisition of licenses to products that are relevant to our
therapeutic areas of focus. We also intend to license out certain
commercial rights of internally developed products to licensees in
territories where such out-licensing would enable us to ensure
development, registration and launch of our product candidates. Our
goal is to become a growth-oriented specialty biopharmaceutical
company by pursuing successful development and commercialization of
our product portfolio, achieving successful commercial presence and
growth, while consistently delivering value to our shareholders,
employees and the medical providers and patients who will benefit
from our products. For more information, visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160315005304/en/
Aeterna Zentaris Inc.Philip A. TheodoreSenior Vice
President843-900-3223ir@aezsinc.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Sep 2023 to Sep 2024